Glenmark Pharmaceuticals Ltd Annually Results

Gross Sales

13,145.84

11,635.46

11,431.94

12,174.2

10,806.03

Excise Duty

0

0

0

0

0

Net Sales

13,145.84

11,635.46

11,431.94

12,174.2

10,806.03

Other Operating Income

175.9

177.64

151.3

130.71

137.9

Other Income

113.72

1,237.32

755.86

166.67

94.76

Total Income

13,435.46

13,050.42

12,339.1

12,471.58

11,038.69

Total Expenditure

11,343.18

11,518.72

10,714.08

10,245.52

8,859.55

PBIDT

2,092.28

1,531.7

1,625.01

2,226.06

2,179.14

Interest

207.07

515.97

349.04

298.1

353.11

PBDT

1,885.22

1,015.73

1,275.98

1,927.96

1,826.03

Depreciation

486.01

581.91

569.17

486.72

443.55

Minority Interest Before NP

0

0

0

0

0

Tax

382.34

1,115.55

416.29

546.65

498.14

Deferred Tax

-30.27

751.79

-86.89

-99.05

-85.75

Reported Profit After Tax

1,047.14

-1,433.52

377.4

993.65

970.09

Minority Interest After NP

0.05

68.15

80.16

51.94

0.05

Net Profit after Minority Interest

1,047.1

-1,501.67

297.25

941.71

970.04

Extra-ordinary Items

-270.94

1,363.72

117.4

-161.95

28.49

Adjusted Profit After Extra-ordinary item

1,318.04

-2,865.39

179.85

1,103.66

941.55

EPS (Unit Curr.)

37.11

-53.22

10.53

33.37

34.38

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

250

250

250

250

250

Equity

28.22

28.22

28.22

28.22

28.22

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.91

13.16

14.21

18.28

20.16

PBDTM(%)

14.34

8.72

11.16

15.83

16.89

PATM(%)

7.96

-12.32

3.3

8.16

8.97